BAYERISCHE JULIUS MAXIMILIANS has a total of 13 patent applications. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Germany. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are GMP ENDOTHERAPEUTICS INC, COMO BIOTECH APS and GINKGO BIOMEDICAL RES INST CO.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Germany | 2 | |
#4 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Surface technology and coating | |
#5 | Machines | |
#6 | Digital networks |
# | Name | Total Patents |
---|---|---|
#1 | Proebstle Hartmut | 2 |
#2 | Wein Martina | 2 |
#3 | Fricke Jochen | 2 |
#4 | Schwab Wilfried | 2 |
#5 | Laser Martin | 2 |
#6 | Hauck Christof | 2 |
#7 | Schmitt Peter | 2 |
#8 | Buenemann Moritz | 2 |
#9 | Schliermann Thomas | 2 |
#10 | Lohse Martin J | 2 |
Publication | Filing date | Title |
---|---|---|
DE102005032252A1 | Transmitting multiple data streams between source and target for communication network, involves assigning bins to corresponding data paths | |
EP1687360A1 | Polymer bonded functional materials | |
EP1644509A1 | Use of fak-related non-kinase in the manufacture of a medicament for the inhibition of stenosis and restenosis | |
EP1571159A1 | Mutein of a bone morphogenetic protein and use thereof | |
EP1536020A1 | Means and methods for optical determination of cAMP in vitro and in vivo | |
DE10313052B3 | Method and device for acquiring data for magnetic resonance imaging with reduced T1 contrast | |
AU2002356735A1 | Multifunctional caffeic acid o-methyltransferase |